Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2231-2240 Newer>

CIO August 1, 2005 Susannah Patton	An End to Medical Forms? Patients could keep all their medical information online using iHealthRecord, a new service that Medem (a joint venture of the American Medical Association and six other medical societies) introduced in May.
InternetNews July 29, 2005 Colin C. Haley	Pharma Markets Online Curtailing direct-to-consumer drug ads sounds like a bitter pill for creative firms, but the fine print suggests an opening for Internet marketers.
The Motley Fool July 29, 2005 Stephen D. Simpson	Psychiatric Solutions' Happy Investors Strong management in an underserved market spells profitable opportunity for the company and its shareholders.
The Motley Fool July 29, 2005 Stephen Ellis	eResearch Misses a Beat Is eResearch Technology a dirt-cheap company or value trap? There are good reasons to suggest that the provider of ECG collection and interpretation services to the pharmaceutical industry does not deserve the shellacking that it has been receiving over the past year.
The Motley Fool July 28, 2005 Stephen D. Simpson	Respironics Still Breathes Freely Despite years of solid growth from Respironics, the respiratory market is still underserved and unappreciated. The history of the past few years would suggest you'll get another chance to buy these shares at a somewhat better valuation.
The Motley Fool July 28, 2005 Stephen D. Simpson	Bristol-Myers' Road to Better Health Bristol-Myers looks toward 2007 and a resumption of real growth. For now, things could be a lot worse. At least investors can't say they're not getting paid to be patient.
The Motley Fool July 28, 2005 Rich Duprey	Chiron's Tragic Quarter The biotech vaccine maker barely breaks even but boasts of its ability to meet full-year expectations.
The Motley Fool July 28, 2005 Stephen D. Simpson	Glaxo Keeps It Going Despite missing sales from the depression franchise, Glaxo managed to post respectable quarterly results.
The Motley Fool July 28, 2005 Stephen D. Simpson	Zimmer at a Simmer Strong demand for reconstructive products keeps this orthopedics company limber. Zimmer's 30-plus trailing price-to-earnings ratio still looks high, but it is in line with this industry's current multiples.
Technology Research News July 27, 2005	Baited molecule fights cancer Many teams of researchers are working on ways to use nanotechnology to deliver anticancer drugs directly to cancerous tissue.
<Older 2231-2240 Newer> Return to current articles.